Nektar Therapeutics (NKTR) Goodwill (2010 - 2022)

Nektar Therapeutics' Goodwill history runs 13 years deep, the most recent figure standing at $76.5 million for Q4 2022.

• In Q4 2022, Goodwill changed 0.0% year-over-year to $76.5 million; the TTM figure through Dec 2022 stood at $76.5 million (changed 0.0% YoY), while the FY2022 annual figure was $76.5 million, changed 0.0% from the prior year.
• Goodwill was $76.5 million for Q4 2022 at Nektar Therapeutics, roughly flat from $76.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $76.5 million in Q1 2018 to a low of $76.5 million in Q1 2018.
• Historically, Goodwill has averaged $76.5 million across 5 years, with a median of $76.5 million in 2018.
• Biggest YoY gain for Goodwill was 0.0% in 2018; the steepest drop was 0.0% in 2018.
• A 5-year view of Goodwill shows it stood at $76.5 million in 2018, then changed by 0.0% to $76.5 million in 2019, then changed by 0.0% to $76.5 million in 2020, then changed by 0.0% to $76.5 million in 2021, then changed by 0.0% to $76.5 million in 2022.
• The last three Goodwill figures came in at $76.5 million (Q4 2022), $76.5 million (Q3 2022), and $76.5 million (Q2 2022), per Business Quant data.